Page last updated: 2024-10-31

ml 7 and Leukemia

ml 7 has been researched along with Leukemia in 1 studies

ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Makishima, M1
Honma, Y1
Hozumi, M1
Sampi, K1
Hattori, M1
Motoyoshi, K1

Other Studies

1 other study available for ml 7 and Leukemia

ArticleYear
Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinase.
    FEBS letters, 1991, Aug-05, Volume: 287, Issue:1-2

    Topics: Azepines; Cell Differentiation; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Monocyt

1991